SUPPLEMENTARY APPENDIX

Online Supplementary Design and Methods
IGHV gene analysis
Polymerase chain reaction (PCR) amplification of the IGH gene rearrangements was performed on genomic DNA from peripheral blood mononuclear cells using subgroup-specific IGHV leader-or framework region 1 primers together with one consensus IGHJ primer as previously described. 1, 2 The PCR products were sequenced using the Big Dye
Terminator Cycle Sequencing Reaction Kit (Applied Biosystems, Foster City, CA, USA) and the ABI 3700 automated DNA sequencer (Applied Biosystems). The obtained IG sequences were submitted to IMGT 3 and GenBank/IgBlast, and aligned to the most homologous germline IGHV, IGHD and IGHJ genes. IGHV gene sequences with less than 98% identity with germline were defined as mutated.
Copy-number analysis
Copy-number analysis using the rank segmentation algorithm and group comparison was performed using BioDiscovery Nexus Copy Number 5.0 software applying the rank segmentation algorithm based on circular binary segmentation. 4 In the preceding interim analysis of a cohort of patients (n=203), we performed real-time quantitative PCR on genomic DNA for selected regions in order to validate gains and losses for adjustment of the settings in the copy-number analysis. 5 A high number of verified alterations (85%) was found for regions larger than 200 kbp, when applying a P value of 1x10 -6 in the copy-number analysis. These criteria were, therefore, applied in the evaluation of copynumber aberrations in the present study. Moreover, the segmentation analysis was performed with a log2ratio cut-off at ±0.15 or ±0.2 for regions greater than 500 kbp and less than 500 kbp, respectively, and a minimum of ten adjacent single nucleotide polymorphism probes to define a gain or loss. Copy number variations (CNV) are polymorphic regions which exist as genomic variants in the population. 6 Since we did not have access to matched normal DNA from the CLL patients for exclusion of CNV, we excluded these non-cancer specific events by matching the array data to CNV regions reported by Redon et al. 
Copy-number neutral loss of heterozygosity analysis
Identification of copy-number neutral loss of heterozygosity (CNN-LOH) that are tumor cell-specific was performed using single nucleotide polymorphism-array and flow-cytometry data on the fraction of normal cells as described elsewhere. 9 Regions with CNN-LOH were visualized in Nexus Copy Number 5.0 software.
Online Supplementary Figure S1 . Genomic display of 13 patients with del(17p) and additional genomic aberrations. Patients are indicated with SCAN-numbers and chromosomes 1-22 are shown on the x-axis. Red and green indicate losses and gains, respectively. The patients with del(17p) have a higher genomic complexity with an average of 9.2 CNA/sample and an average CNA size of 15.6 Mbp.
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